GlassScriptPhysician profile
James Anthony Arreche
NPI 1548264393
$5,137.23
in general payments reported to CMS, 2019-2025
19 companies · $1,693 in 2025
The $1,693 reported for 2025 was more than what 95% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $385 · 2022: $975 · 2023: $714 · 2024: $1,370 · 2025: $1,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,777.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,403.67 | 2022-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $1,245.20 | 2021-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Konect Resilia |
| Atricure, INC. | $1,174.96 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Astrazeneca Pharmaceuticals LP | $329.66 | 2021-2025 | Imfinzi |
| Davol INC. | $176.63 | 2023-2025 | Progel Applicator Spray Tips |
| Abiomed | $127.43 | 2023-2024 | Impella |
| Arthrex, INC. | $106.45 | 2025 | |
| Stability Biologics, LLC | $98.49 | 2022 | |
| Baxter Healthcare | $92.33 | 2022-2025 | Coseal, Preveleak |
| Amgen INC. | $90.51 | 2025 | Tezspire |
| Ethicon US, LLC | $53.39 | 2021-2024 | Vistaseal, Evarrest, Surgicel Nu-Knit |
| Lsi Solutions INC | $43.08 | 2024 | Cor-Knot |
| Silk Road Medical, INC. | $39.80 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Depuy Synthes Sales INC. | $35.19 | 2025 | Matrixrib |
| Merck Sharp & Dohme LLC | $30.48 | 2024 | Keytruda |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.21 | 2021 | |
| Stryker Corporation | $23.80 | 2021 | |
| Biotissue Holdings INC. | $23.49 | 2023 | |
| Zimmer Biomet Holdings, INC. | $18.46 | 2025 | Venapax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Arreche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.